Home / Medicine / Vastarel

Vastarel

Vastarel contains trimetazidine, a cardiac therapy agent classified within the antianginal and cardioprotective category, and it is registered in 19 countries worldwide. The brand is encountered by travellers and expatriates across a notably mixed geography — from Western Europe through the Mediterranean basin into Latin America and Southeast Asia — which makes it a common point of reference for patients moving between very different healthcare systems.

Trimetazidine is prescribed in the management of angina pectoris and is also indicated in some markets for symptoms such as lightheadedness and dizziness associated with certain circulatory presentations. Its pharmacological profile spans several categories listed for the molecule, including antianginal, cardioprotective, and antihypoxic activity, with an emphasis on improving cellular energy metabolism in the heart. The structured indication section further down this page lists the registered uses recognised by national regulators in the markets where Vastarel is sold.

Representative markets where Vastarel is available include France, Brazil, Egypt, Malaysia, and Ireland — a geographic spread that reflects the brand's long history in cardiology prescribing rather than a single regional cluster. Travellers should be aware that trimetazidine is not registered everywhere; in particular, several major markets either do not authorise the molecule or restrict its use, so a Vastarel prescription from one country will not always translate directly to a refill in another. A local pharmacist can confirm regional availability and the brand names under which trimetazidine is supplied.

Other medications used in the management of angina belong to several distinct pharmacological classes, and what is appropriate for a given patient depends on individual cardiac history and concurrent therapy. Anyone taking Vastarel, considering it, or trying to identify a local equivalent while abroad should treat the conversation as a clinical one and involve a healthcare provider before making any change.

Countries
Austria Brazil Colombia Denmark Ecuador Egypt France Greece Ireland Italy Lebanon Malaysia Malta Oman Philippines Portugal Tunisia Turkey Vietnam
Diseases
Angina Pectoris Lightheadedness,Dizzy
Ingredients
Trimetazidine
Drug Actions
Hypotensive Antianginal Cardiac therapy Antihypoxic Cardioprotective Coronary deglutating Improving energy metabolism

Drugs with the same active ingredients

Vastarel lp Bustidin Cardimax (trimetazidine) Tacirel lm Angimet (trimetazidine) Angimet-mr Anginox Angirid-mr Angivent-mr Antoris-mr Feelnor Feelnor-mr Preductal mr Trimetacor Trimetazidin pharmas Apstar Energotrim Moduxin mr Neotri mr Prectazidine mr

Frequently asked questions

What conditions does Vastarel treat?

Vastarel is prescribed in the management of angina pectoris and, in some markets, for symptoms such as lightheadedness and dizziness linked to certain circulatory presentations. The active ingredient is described across categories including antianginal, cardioprotective, and antihypoxic activity, with a focus on improving cellular energy metabolism in cardiac tissue. The structured indication block on this page details the registered uses in the markets where Vastarel is authorised.

Which active substance is in Vastarel?

Vastarel contains trimetazidine, a molecule classified as a cardiac therapy agent with antianginal and cardioprotective properties. Trimetazidine circulates internationally under several brand names in markets where it is registered. Regulatory status varies significantly — the molecule is authorised in many countries but restricted or unavailable in others — so the same active ingredient is not uniformly accessible worldwide.

In how many countries is Vastarel available?

Vastarel is registered in 19 countries, with a footprint spanning Western Europe, the Mediterranean, Latin America, and parts of Southeast Asia. Examples include France, Brazil, Egypt, Malaysia, Lebanon, Ireland, and the Philippines. If your country is not represented on this list, a local pharmacist can confirm whether trimetazidine is authorised in that market and, if so, under which brand name it is supplied.

Are there other medications with the same active ingredient as Vastarel?

Trimetazidine is sold under several brand names in the markets where it is registered, so equivalent products exist regionally. Medications used in the management of angina also span several distinct pharmacological classes beyond trimetazidine, and these are not freely interchangeable — class and individual molecule both matter clinically. To identify a local trimetazidine product, search the active ingredient on Pill2Trip or ask a pharmacist in your country.

Should I consult a doctor before taking Vastarel?

Yes. Vastarel is a prescription medication, and angina therapy in general is calibrated to a patient's full cardiac history, concurrent medications, and individual circumstances. This is especially relevant for travellers and expatriates, because trimetazidine is not authorised in every country and prescription pathways differ between regulators. Any decision to start, continue, switch, or substitute the medication should involve a healthcare provider familiar with the patient.

Vastarel

Available in 19 countries